Answers are grounded in this paper and cite their sources.
The rise of treatment-resistant pathogens and emerging infectious diseases (EIDs) has renewed interest in medicinal plants as alternative therapeutic agents. While modern medicine has made significant strides, the limitations of synthetic drugs—such as antibiotic resistance and slow drug development—necessitate complementary solutions. This paper explores the historical and contemporary roles of medicinal plants, their phytochemical properties, and mechanisms of action against pathogens. Case studies highlight successful applications, while discussions on regulatory, ethical, and sustainability challenges emphasize the need for responsible integration into global healthcare. Future research must focus on scientific validation, sustainable harvesting, and interdisciplinary collaboration to unlock the full potential of plant-based medicine in combating EIDs.
No takes yet. Share an insight, caveat, or question.
Wambui Kibibi J. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: